{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:17:54Z","timestamp":1767665874328},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12288-018-1029-7","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:00:26Z","timestamp":1539194426000},"page":"265-271","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia"],"prefix":"10.1007","volume":"35","author":[{"given":"\u0130lay","family":"Berke Mente\u015fe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep Arzu","family":"Yegin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanem","family":"G\u00f6k\u00e7en","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z\u00fcbeyde Nur","family":"\u00d6zkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fcnci","family":"Ya\u011fc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"issue":"15","key":"1029_CR1","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1002\/cncr.31538","volume":"124","author":"BL Andersen","year":"2018","unstructured":"Andersen BL, Goyal NG, Weiss DM, Westbrook TD, Maddocks KJ, Byrd JC, Johnson AJ (2018) Cells, cytokines, chemokines, and cancer stress: a biobehavioral study of patients with chronic lymphocytic leukemia. Cancer 124(15):3240\u20133248","journal-title":"Cancer"},{"issue":"5","key":"1029_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ajh.23979","volume":"90","author":"M Hallek","year":"2015","unstructured":"Hallek M (2015) Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am J Hematol 90(5):446\u2013460","journal-title":"Am J Hematol"},{"issue":"10","key":"1029_CR3","doi-asserted-by":"publisher","first-page":"13617","DOI":"10.1007\/s13277-016-5182-z","volume":"37","author":"M Jasek","year":"2016","unstructured":"Jasek M, Bojarska-Junak A, Wagner M, Sobczy\u0144ski M, Wo\u0142owiec D, Roli\u0144ski J, Karabon L, Ku\u015bnierczyk P (2016) Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia. Tumour Biol 37(10):13617\u201313626","journal-title":"Tumour Biol"},{"issue":"1","key":"1029_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrclinonc.2010.167","volume":"8","author":"P Cramer","year":"2011","unstructured":"Cramer P, Hallek M (2011) Prognostic factors in chronic lymphocytic leukemia-what do we need to know? Nat Rev Clin Oncol 8(1):38\u201347","journal-title":"Nat Rev Clin Oncol"},{"key":"1029_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","volume":"24","author":"JA Burger","year":"2014","unstructured":"Burger JA, Gribben JG (2014) The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies. Semin Cancer Biol 24:71\u201381","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1029_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1124\/jpet.116.236075","volume":"359","author":"AM Nicoletti","year":"2016","unstructured":"Nicoletti AM, Kenny CH, Khalil AM, Pan Q, Ralph KL, Ritchie J, Venkataramani S, Presky DH, DeWire SM, Brodeur SR (2016) Unexpected potency differences between B-cell-activating factor (BAFF) antagonist antibodies against various forms of BAFF: trimer, 60-Mer, and membrane-bound. J Pharmacol Exp Ther 359(1):37\u201344","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1029_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00277-014-2173-2","volume":"94","author":"YJ Li","year":"2015","unstructured":"Li YJ, Li ZM, Xia ZJ, Li S, Xia Y, Huang HQ, Huang JJ, Yi PY, Jiang WQ (2015) High APRIL but not BAFF serum levels are associated with poor outcome in patients with follicular lymphoma. Ann Hematol 94(1):79\u201388","journal-title":"Ann Hematol"},{"issue":"8","key":"1029_CR8","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","volume":"103","author":"J Moreaux","year":"2004","unstructured":"Moreaux J, Legouffe E, Jourdan E, Quittet P, R\u00e8me T, Lugagne C, Moine P, Rossi JF, Klein B, Tarte K (2004) BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103(8):3148\u20133157","journal-title":"Blood"},{"issue":"2","key":"1029_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1182\/blood-2006-04-015958","volume":"109","author":"A Chiu","year":"2007","unstructured":"Chiu A, Xu W, He B, Dillon SR, Gross JA, Sievers E, Qiao X, Santini P, Hyjek E, Lee JW, Cesarman E, Chadburn A, Knowles DM, Cerutti A (2007) Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 109(2):729\u2013739","journal-title":"Blood"},{"issue":"7","key":"1029_CR10","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.molonc.2015.03.010","volume":"9","author":"F Oden","year":"2015","unstructured":"Oden F, Marino SF, Brand J, Scheu S, Kriegel C, Olal D, Takvorian A, Westermann J, Yilmaz B, Hinz M, Daumke O, H\u00f6pken UE, M\u00fcller G, Lipp M (2015) Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma. Mol Oncol 9(7):1348\u20131358","journal-title":"Mol Oncol"},{"issue":"6","key":"1029_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0961203315608254","volume":"25","author":"DC Salazar-Camarena","year":"2015","unstructured":"Salazar-Camarena DC, Ortiz-Lazareno PC, Cruz A, Oregon-Romero E, Machado-Contreras JR, Mu\u00f1oz-Valle JF, Orozco-L\u00f3pez M, Mar\u00edn-Rosales M, Palafox-S\u00e1nchez CA (2015) Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus 25(6):582\u2013592","journal-title":"Lupus"},{"issue":"11","key":"1029_CR12","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/art.22929","volume":"56","author":"K Nagatani","year":"2007","unstructured":"Nagatani K, Itoh K, Nakajima K, Kuroki H, Katsuragawa Y, Mochizuki M, Aotsuka S, Mimori A (2007) Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum 56(11):3554\u20133563","journal-title":"Arthritis Rheum"},{"issue":"22","key":"1029_CR13","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1182\/blood-2011-05-353961","volume":"118","author":"S Tsuji","year":"2011","unstructured":"Tsuji S, Cortes\u00e3o C, Bram RJ, Platt JL, Cascalho M (2011) TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow. Blood 118(22):5832\u20135839","journal-title":"Blood"},{"issue":"5","key":"1029_CR14","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.3892\/ol.2016.5095","volume":"12","author":"H Dou","year":"2016","unstructured":"Dou H, Yan Z, Zhang M, Xu X (2016) APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer. Oncol Lett 12(5):3351\u20133355","journal-title":"Oncol Lett"},{"issue":"5","key":"1029_CR15","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","volume":"172","author":"B He","year":"2004","unstructured":"He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A (2004) Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL. J Immunol 172(5):3268\u20133279","journal-title":"J Immunol"},{"issue":"2","key":"1029_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1182\/blood-2003-02-0540","volume":"103","author":"C Kern","year":"2004","unstructured":"Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PY, Feldblum S, Kolb JP (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103(2):679\u2013688","journal-title":"Blood"},{"issue":"3","key":"1029_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1182\/blood-2004-03-0889","volume":"106","author":"M Nishio","year":"2005","unstructured":"Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC, Zvaifler NJ, Kipps TJ (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106(3):1012\u20131020","journal-title":"Blood"},{"issue":"2","key":"1029_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","volume":"109","author":"T Endo","year":"2007","unstructured":"Endo T, Nishio M, Enzler T, Cottam HB, Fukuda T, James DF, Karin M, Kipps TJ (2007) BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 109(2):703\u2013710","journal-title":"Blood"},{"issue":"12","key":"1029_CR19","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.4049\/jimmunol.1102066","volume":"188","author":"M Cols","year":"2012","unstructured":"Cols M, Barra CM, He B, Puga I, Xu W, Chiu A, Tam W, Knowles DM, Dillon SR, Leonard JP, Furman RR, Chen K, Cerutti A (2012) Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. J Immunol 188(12):6071\u20136083","journal-title":"J Immunol"},{"issue":"24","key":"1029_CR20","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1182\/blood-2013-04-497693","volume":"122","author":"V Lascano","year":"2013","unstructured":"Lascano V, Guadagnoli M, Schot JG, Luijks DM, Guikema JE, Cameron K, Hahne M, Pals S, Slinger E, Kipps TJ, van Oers MH, Eldering E, Medema JP, Kater AP (2013) Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model. Blood 122(24):3960\u20133963","journal-title":"Blood"},{"issue":"15","key":"1029_CR21","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.ejca.2008.07.007","volume":"44","author":"P Mhawech-Fauceglia","year":"2008","unstructured":"Mhawech-Fauceglia P, Allal A, Odunsi K, Andrews C, Herrmann FR, Huard B (2008) Role of the tumour necrosis family ligand APRIL in solid tumour development: retrospective studies in bladder, ovarian and head and neck carcinomas. Eur J Cancer 44(15):2097\u20132100","journal-title":"Eur J Cancer"},{"issue":"6","key":"1029_CR22","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","volume":"188","author":"M Hahne","year":"1998","unstructured":"Hahne M, Kataoka T, Schr\u00f6ter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D, Tschopp J (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188(6):1185\u20131190","journal-title":"J Exp Med"},{"issue":"11","key":"1029_CR23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.prp.2015.07.011","volume":"211","author":"C Lee","year":"2015","unstructured":"Lee C, Park JW, Suh JH, Moon KC (2015) High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma. Pathol Res Pract 211(11):824\u2013828","journal-title":"Pathol Res Pract"},{"issue":"2","key":"1029_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1309\/AJCP4JP8BZOMHEAW","volume":"141","author":"Z Qian","year":"2014","unstructured":"Qian Z, Qingshan C, Chun J, Huijun Z, Feng L, Qiang W, Qiang X, Min Z (2014) High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non\u2013small cell lung cancer. Am J Clin Pathol 141(2):226\u2013233","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"1029_CR25","doi-asserted-by":"publisher","first-page":"e55298","DOI":"10.1371\/journal.pone.0055298","volume":"8","author":"G Wang","year":"2013","unstructured":"Wang G, Wang F, Ding W, Wang J, Jing R, Li H, Wang X, Wang Y, Ju S, Wang H (2013) APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K\/Akt pathway. PLoS ONE 8(1):e55298","journal-title":"PLoS ONE"},{"issue":"5","key":"1029_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/carcin\/bgv020","volume":"36","author":"A Garc\u00eda-Castro","year":"2015","unstructured":"Garc\u00eda-Castro A, Zonca M, Florindo-Pinheiro D, Carvalho-Pinto CE, Cordero A, Guti\u00e9rrez del Fernando B, Garc\u00eda-Grande A, Ma\u00f1es S, Hahne M, Gonz\u00e1lez-Su\u00e1rez E, Planelles L (2015) APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer. Carcinogenesis 36(5):574\u2013584","journal-title":"Carcinogenesis"},{"issue":"10","key":"1029_CR27","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1515\/CCLM.2011.608","volume":"49","author":"F Wang","year":"2011","unstructured":"Wang F, Chen L, Ding W, Wang G, Wu Y, Wang J, Luo L, Cong H, Wang Y, Ju S, Shao J, Wang H (2011) Serum APRIL a potential tumor marker in pancreatic cancer. Clin Chem Lab Med 49(10):1715\u20131719","journal-title":"Clin Chem Lab Med"},{"key":"1029_CR28","doi-asserted-by":"crossref","unstructured":"Mamara A, Germenis AE, Kompoti M, Palassopoulou M, Mandala E, Banti A, Giannakoulas N, Speletas M (2015) TACI expression and signaling in chronic lymphocytic leukemia. J Immunol Res 478753","DOI":"10.1155\/2015\/478753"},{"key":"1029_CR29","doi-asserted-by":"crossref","unstructured":"Kyrtsonis MC, Sarris K, Koulieris E, Maltezas D, Nikolaou E, Angelopoulou MK, Bartzis V, Tzenou T, Dimou M, Siakandaris MP, Viniou NA, Sachanas S, Kalpadakis C, Sfikakis PP, Pangalis GA, Panayiotidis P (2014) Serum soluble TACI, a BLyS receptor is a powerful prognostic marker of outcome in chronic lymphocytic leukemia. Biomed Res Int 159632","DOI":"10.1155\/2014\/159632"},{"issue":"9","key":"1029_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3324\/haematol.10317","volume":"92","author":"L Planelles","year":"2017","unstructured":"Planelles L, Castillo-Guti\u00e9rrez S, Medema JP, Morales-Luque A, Merle-B\u00e9ral H, Hahne M (2017) APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica 92(9):1284\u20131285","journal-title":"Haematologica"},{"issue":"3","key":"1029_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2567.2006.02377.x","volume":"118","author":"S Haiat","year":"2006","unstructured":"Haiat S, Billard C, Quiney C, Ajchenbaum-Cymbalista F, Kolb JP (2006) Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 118(3):281\u2013292","journal-title":"Immunology"},{"issue":"4","key":"1029_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1600-0609.2010.01482.x","volume":"85","author":"S Molica","year":"2010","unstructured":"Molica S, Digiesi G, Battaglia C, Cutrona G, Antenucci A, Molica M, Giannarelli D, Sperduti I, Gentile M, Morabito F, Ferrarini M (2010) BAFF serum level predicts time to first treatment in early chronic lymphocytic leukemia. Eur J Haematol 85(4):314\u2013320","journal-title":"Eur J Haematol"},{"issue":"1","key":"1029_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/leu.2015.174","volume":"30","author":"D Saulep-Easton","year":"2016","unstructured":"Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C, Mackay F (2016) The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia 30(1):163\u2013172","journal-title":"Leukemia"},{"issue":"10","key":"1029_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.leukres.2009.03.030","volume":"33","author":"A Bojarska-Junak","year":"2009","unstructured":"Bojarska-Junak A, Hus I, Chocholska S, Wasik-Szczepanek E, Sieklucka M, Dmoszy\u0144ska A, Roli\u0144ski J (2009) BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features. Leuk Res 33(10):1319\u20131327","journal-title":"Leuk Res"},{"issue":"11","key":"1029_CR35","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3109\/10428194.2011.591008","volume":"52","author":"G Ferrer","year":"2011","unstructured":"Ferrer G, Hodgson K, Pereira A, Juan M, Elena M, Colomer D, Rou\u00e9 G, Aymerich M, Baumann T, Montserrat E, Moreno C (2011) Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia. Leuk Lymphoma 52(11):2064\u20132068","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1029_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4049\/jimmunol.1102321","volume":"188","author":"M Kreuzaler","year":"2012","unstructured":"Kreuzaler M, Rauch M, Salzer U, Birmelin J, Rizzi M, Grimbacher B, Plebani A, Lougaris V, Quinti I, Thon V, Litzman J, Schlesier M, Warnatz K, Thiel J, Rolink AG, Eibel H (2012) Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. J Immunol 188(1):497\u2013503","journal-title":"J Immunol"},{"issue":"1","key":"1029_CR37","first-page":"46","volume":"36","author":"A Bojarska-Junak","year":"2011","unstructured":"Bojarska-Junak A, Hus I, Sieklucka M, Surdacka A, Kusz ML, Wasik-Szczepanek E, Dmoszynska A, Rolinski J (2011) The role of TACI expression in chronic lymphocytic leukemia. Cent Eur J Immunol 36(1):46\u201350","journal-title":"Cent Eur J Immunol"},{"issue":"13","key":"1029_CR38","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1182\/blood-2011-06-275610","volume":"118","author":"F Malavasi","year":"2011","unstructured":"Malavasi F, Deaglio S, Damle R, Cutrona G, Ferrarini M, Chiorazzi N (2011) CD38 and chronic lymphocytic leukemia: a decade later. Blood 118(13):3470\u20133478","journal-title":"Blood"},{"issue":"5","key":"1029_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1615\/CritRevImmunol.v35.i5.50","volume":"35","author":"S Burgler","year":"2015","unstructured":"Burgler S (2015) Role of CD38 expression in diagnosis and pathogenesis of chronic lymphocytic leukemia and its potential as therapeutic target. Crit Rev Immunol 35(5):417\u2013432","journal-title":"Crit Rev Immunol"},{"issue":"4","key":"1029_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/bjh.12645","volume":"164","author":"G Ferrer","year":"2014","unstructured":"Ferrer G, Bosch R, Hodgson K, Tejero R, Rou\u00e9 G, Colomer D, Montserrat E, Moreno C (2014) B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL. Br J Haematol 164(4):570\u2013578","journal-title":"Br J Haematol"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-018-1029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-018-1029-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-018-1029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T23:20:42Z","timestamp":1570663242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-018-1029-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1007\/s12288-018-1029-7","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}